{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:59:42Z","timestamp":1776409182566,"version":"3.51.2"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016545","name":"Roche Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The US Centers for Disease Control and Prevention recommends HIV testing every 3 months in oral PrEP users. We performed a national assessment of HIV testing compliance among oral PrEP users.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analyzed 408 910 PrEP prescriptions issued to 39 809 PrEP users using a national insurance claims database that contained commercial and Medicaid claims. We identified PrEP use based on pharmacy claims and outpatient diagnostic coding. We evaluated the percentage of PrEP prescription refills without HIV testing (identified by CPT codes) within the prior 3, 6, and 12 months using time to event methods. We performed subgroup and multivariate analyses by age, gender, race, insurance type, and geography.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 39 809 persons, 36 197 were commercially insured, 3612 were Medicaid-insured, and 96% identified as male; the median age (interquartile range) was 34 (29\u201344) years, and the Medicaid-insured PrEP users were 24% Black\/African American, 44% White, and 9% Hispanic\/Latinx. Within the prior 3, 6, and 12 months, respectively, the percentage of PrEP prescription fills in individuals without HIV Ag\/Ab testing was 34.3% (95% CI, 34.2%\u201334.5%), 23.8% (95% CI, 23.7%\u201323.9%), and 16.6% (95% CI, 16.4%\u201316.7%), and the percentage without any type of HIV test was 25.8% (95% CI, 25.6%\u201325.9%), 14.6% (95% CI, 14.5%\u201314.7%), and 7.8% (95% CI, 7.7%\u20137.9%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Approximately 1 in 3 oral PrEP prescriptions were filled in persons who had not received an HIV Ag\/Ab test within the prior 3 months, with evidence of health disparities. These findings inform clinical PrEP monitoring efforts and compliance with national HIV testing guidance to monitor PrEP users.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofae254","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T13:22:50Z","timestamp":1716470570000},"source":"Crossref","is-referenced-by-count":4,"title":["High Rates of Missed HIV Testing Among Oral PrEP Users in the United States From 2018\u20132021: A National Assessment on Compliance With HIV Testing Recommendations of the CDC PrEP Guidelines"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4182-6349","authenticated-orcid":false,"given":"Jason","family":"Baron","sequence":"first","affiliation":[{"name":"Roche Diagnostics , Indianapolis, Indiana , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Tchelidze","sequence":"additional","affiliation":[{"name":"Roche Diagnostics , Indianapolis, Indiana , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"LaBrot","sequence":"additional","affiliation":[{"name":"Roche Molecular Systems , Pleasanton, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Yao","sequence":"additional","affiliation":[{"name":"Mayo Clinic , Rochester, Minnesota , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth H","family":"Mayer","sequence":"additional","affiliation":[{"name":"Fenway Health and Harvard Medical School , Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Kuritzkes","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital and Harvard Medical School , Boston, Massachusetts , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Robinson","sequence":"additional","affiliation":[{"name":"Roche Diagnostics , Indianapolis, Indiana , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupa R","family":"Patel","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine , St Louis, Missouri , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"2024053113423304400_ofae254-B1"},{"key":"2024053113423304400_ofae254-B2","author":"Center for Disease Control and Prevention"},{"key":"2024053113423304400_ofae254-B3","doi-asserted-by":"crossref","first-page":"j5011","DOI":"10.1136\/bmj.j5011","article-title":"Recent advances in pre-exposure prophylaxis for HIV","volume":"359","author":"Desai","year":"2017","journal-title":"BMJ"},{"key":"2024053113423304400_ofae254-B4","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2018.1917","article-title":"HIV preexposure prophylaxis: a review","volume":"319","author":"Riddell","year":"2018","journal-title":"JAMA"},{"key":"2024053113423304400_ofae254-B5","doi-asserted-by":"crossref","first-page":"e25419","DOI":"10.1002\/jia2.25419","article-title":"Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review","volume":"22","author":"Elliott","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"2024053113423304400_ofae254-B6","author":"US Public Health Service","year":"2021"},{"key":"2024053113423304400_ofae254-B7","author":"US Public Health Service","year":"2017"},{"key":"2024053113423304400_ofae254-B8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/infdis\/jix595","article-title":"Laboratory testing of a cohort of commercially insured users of HIV preexposure prophylaxis in the United States, 2011\u20132015","volume":"217","author":"Huang","year":"2018","journal-title":"J Infect Dis"},{"key":"2024053113423304400_ofae254-B9","author":"Metative"},{"key":"2024053113423304400_ofae254-B10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/09540121.2022.2067318","article-title":"Initiation of HIV pre-exposure prophylaxis among youth in the United States, 2015\u20132018","volume":"35","author":"Barocas","year":"2023","journal-title":"AIDS Care"},{"key":"2024053113423304400_ofae254-B11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.36469\/jheor.2023.56928","article-title":"Economic burden of HIV in a commercially insured population in the United States","volume":"10","author":"Chen","year":"2023","journal-title":"J Health Econ Outcomes Res"},{"key":"2024053113423304400_ofae254-B12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/cid\/ciaa037","article-title":"Persistence with human immunodeficiency virus pre-exposure prophylaxis in the United States, 2012\u20132017","volume":"72","author":"Huang","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024053113423304400_ofae254-B13","doi-asserted-by":"crossref","first-page":"e2221346","DOI":"10.1001\/jamanetworkopen.2022.21346","article-title":"Prevalence of HIV preexposure prophylaxis prescribing among persons with commercial insurance and likely injection drug use","volume":"5","author":"Streed","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2024053113423304400_ofae254-B14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/cid\/ciw701","article-title":"Uptake of HIV preexposure prophylaxis among commercially insured persons\u2014United States, 2010\u20132014","volume":"64","author":"Wu","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2024053113423304400_ofae254-B15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/apc.2023.0062","article-title":"Adherence to HIV pre-exposure prophylaxis testing guidelines in the United States","volume":"37","author":"McCormick","year":"2023","journal-title":"AIDS Patient Care STDS"},{"key":"2024053113423304400_ofae254-B16","author":"World Health Organization","year":"2023"},{"key":"2024053113423304400_ofae254-B17","author":"American Medical Association","year":"2023"},{"key":"2024053113423304400_ofae254-B18","author":"Food and Drug Administration","year":"2023"},{"key":"2024053113423304400_ofae254-B19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/0962280209105023","article-title":"Interval censoring","volume":"19","author":"Zhang","year":"2010","journal-title":"Stat Methods Med Res"},{"key":"2024053113423304400_ofae254-B20","author":"RStudio Team","year":"2023"},{"key":"2024053113423304400_ofae254-B21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cca.2013.09.027","article-title":"The role of informatics and decision support in utilization management","volume":"427","author":"Baron","year":"2014","journal-title":"Clin Chim Acta"},{"key":"2024053113423304400_ofae254-B22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cll.2019.01.002","article-title":"Operational aspects of a clinical decision support program","volume":"39","author":"Procop","year":"2019","journal-title":"Clin Lab Med"},{"key":"2024053113423304400_ofae254-B23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cca.2013.09.031","article-title":"Utilization management in microbiology","volume":"427","author":"Branda","year":"2014","journal-title":"Clin Chim Acta"},{"key":"2024053113423304400_ofae254-B24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.contraception.2015.12.018","article-title":"United States family planning providers\u2019 knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey","volume":"93","author":"Seidman","year":"2016","journal-title":"Contraception"},{"key":"2024053113423304400_ofae254-B25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11606-016-3903-z","article-title":"A cross-sectional online survey of HIV pre-exposure prophylaxis adoption among primary care physicians","volume":"32","author":"Blackstock","year":"2017","journal-title":"J Gen Intern Med"},{"key":"2024053113423304400_ofae254-B26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s11606-016-3899-4","article-title":"Pre-exposure prophylaxis: a narrative review of provider behavior and interventions to increase prep implementation in primary care","volume":"32","author":"Silapaswan","year":"2017","journal-title":"J Gen Intern Med"},{"key":"2024053113423304400_ofae254-B27","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1016\/S2352-3018(22)00126-6","article-title":"Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya: an open-label, randomised, non-inferiority, implementation trial","volume":"9","author":"Ngure","year":"2022","journal-title":"Lancet HIV"},{"key":"2024053113423304400_ofae254-B28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11904-022-00617-x","article-title":"Examining the use of HIV self-testing to support PrEP delivery: a systematic literature review","volume":"19","author":"Kiptinness","year":"2022","journal-title":"Curr HIV\/AIDS Rep"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae254\/57767877\/ofae254.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/5\/ofae254\/57977836\/ofae254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/5\/ofae254\/57977836\/ofae254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T21:49:51Z","timestamp":1717192191000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae254\/7676688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,4,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae254","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,4,26]]},"article-number":"ofae254"}}